.png
)
Doc No. CDSCO/MD/GD/MDSW/01/2026 | Circular F. No. MED-16028/2/2025-eoffice dated 21.07.2026 The Central Drugs Standard Control Organization (CDSCO), Medical Devices Division, has notified the final Guidance Document on Medical Device Software (MDSW), signed by Dr. Rajeev Singh Raghuvanshi, Drugs Controller General…
File Ref: Enforc-11021(11)/106/2024 · CDSCO / Maharashtra FDA India's pharma industry has a brand-name problem — and a single antacid brand just showed regulators exactly why it matters. Exhibit A A Notice That Arrived Right on Time On July 6,…
Regulatory Update | CDSCO / DCC | July 2026 The Drugs Consultative Committee (DCC), at its 69th meeting, took up a proposal aimed at tightening control over one of the least regulated links in the pharmaceutical supply chain: the manufacturers…
High-Alcohol Oral Formulations Move Into Schedule H1: What G.S.R. 607(E) Means for Manufacturers The Drugs (Tenth Amendment) Rules, 2026 tighten the exemption net around alcohol-based oral medicines — and bring a familiar public health concern squarely into prescription-drug territory. Notification:…
69th DCC Recommends Comprehensive Regulatory Mechanism to Curb Unapproved Drugs and FDCs Minutes of the 69th Drugs Consultative Committee (DCC) meeting held on 24.06.2026 — Agenda Nos. 2 & 3 Meeting: 69th DCC, held on 24.06.2026 Agenda 2: Comprehensive Regulatory…